Biosurgery in Orthopedic Procedures: Improving Bone Healing
The Rise of Ambulatory Surgical Centers
The global Biosurgery Market is a dynamic and expanding industry, with a market size of over USD 11.5 billion in 2024 and a projected value of approximately USD 20 billion by 2035. This impressive growth, with a CAGR of 5.12%, is significantly influenced by the rise of ambulatory surgical centers (ASCs). These outpatient facilities are becoming increasingly popular for their cost-effectiveness, convenience, and ability to perform a wide range of surgical procedures. As ASCs perform more complex surgeries, the demand for advanced biosurgical products, such as hemostatic agents, surgical sealants, and adhesion barriers, is soaring. These products are crucial for ensuring successful outcomes in a fast-paced outpatient setting, where minimizing blood loss and preventing complications are paramount. The market is also benefiting from a shift in patient preference for outpatient procedures, which offer shorter hospital stays and faster recovery times.
Ambulatory surgical centers are a key end-user segment for the biosurgery market, with a diverse range of products being used in various specialties. For instance, hemostatic agents are essential for controlling bleeding in general surgery and orthopedic procedures, while surgical sealants are crucial for preventing fluid leakage in thoracic and hernia repair surgeries. The market is also seeing a rise in products that are specifically designed for use in ASCs, with a focus on ease of use and cost-effectiveness. The increasing number of surgical procedures performed in these facilities, coupled with a growing emphasis on improving operational efficiency, ensures a sustained demand for biosurgical solutions. The market's growth in this segment is also being supported by favorable reimbursement policies and a greater investment in healthcare infrastructure, further solidifying the role of biosurgery in outpatient care.